Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page
- Check4 days agoChange DetectedRecord History now shows per-version changes for Study Status and Contacts/Locations (Revision: v3.5.0, added 2026-03-17/18).SummaryDifference0.5%

- Check11 days agoChange DetectedA new revision entry v3.4.3 was added and the previous v3.4.2 was removed from the record history. This update affects revision tracking rather than study content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.4.2 was added to the history. The funding-lapse notice and the earlier revision note (v3.4.1) were removed.SummaryDifference0.7%

- Check47 days agoChange DetectedAdded a government funding notice and a new revision entry (v3.4.1) to the history, and removed the previous revision entry (v3.4.0).SummaryDifference0.7%

- Check54 days agoChange DetectedThe page history now includes a 'Show glossary' option, green highlights for additions, red highlights for deletions, and an updated revision indicator to v3.4.0.SummaryDifference0.9%

- Check68 days agoChange DetectedThe history now includes a new version entry (v3.3.4) and removes v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.